2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 多本ABS四星！优质经管国际期刊列表 | 热 全流程投稿协助套餐服务 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY CRIT REV ONCOL HEMAT （此期刊被最新的JCR期刊SCIE收录） LetPub评分 7.8
65人评分
我要评分
声誉 8.6 影响力 6.9 速度 6.7 | |||||||||||||||||||||||||
| 期刊ISSN | 1040-8428 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||
| E-ISSN | 1879-0461 | |||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：6.19 | |||||||||||||||||||||||||
| 2025-2026自引率 | 1.6%点击查看自引率趋势图 | |||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 6.303数据由网友[galaxy1758]收集提供 | |||||||||||||||||||||||||
| h-index | 111 | |||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||
| 期刊官方网站 | https://www.sciencedirect.com/journal/critical-reviews-in-oncology-hematology | |||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/CROH | |||||||||||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/critical-reviews-in-oncology-hematology/publish/guide-for-authors | |||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Mitophagy in lymph node metastasis: Mechanisms, immune consequences and therapeutic opportunities Author: Ju, Jun; Zhu, Wangyang; Zhang, Yang Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105386 Molecular understanding and clinical aspects of adoptive cellular immunotherapy in prostate cancer Author: Du, Xinhong; Yan, Zhenhong; Su, Peng; Liang, Hongyuan; Dong, Dan; Wang, Kefeng Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105395 Macrophages in colorectal cancer: Origin, function and significance of targeted therapy Author: Zhu, Yu; Xue, Yuan; Jiang, Jingzhi; Jin, Xuemei; Li, Li; Piao, Lihua Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105391 Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments Author: Zhao, Peng-Yu; Wang, Kai-Kai; Zhang, Meng-Meng; Cao, Ze-Lin; Jin, Wei-Lin; Rozpedek-Kaminska, Wioletta Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105409 | |||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY的语言要求，还能让CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | Yes (Hybrid，可自选是否OA) | |||||||||||||||||||||||||
| 通讯方式 | ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 | |||||||||||||||||||||||||
| 出版商 | Elsevier Ireland Ltd | |||||||||||||||||||||||||
| 涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 1983 | |||||||||||||||||||||||||
| 年文章数 | 385点击查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 31.46% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 0.00% | |||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
  | ||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1040-8428%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 偏慢,4-8周 来源Elsevier官网： 平均27.3周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 一般 来源Elsevier官网： 83% | |||||||||||||||||||||||||
| APC文章处理费信息 | 版面费：If OA, USD 4180. https://www.sciencedirect.com/journal/critical-reviews-in-oncology-hematology/publish/open-access-options | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均8.8周 | |||||||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Mitophagy in lymph node metastasis: Mechanisms, immune consequences and therapeutic opportunities Author: Ju, Jun; Zhu, Wangyang; Zhang, Yang Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105386 PubMed DOI |
| 2. | Molecular understanding and clinical aspects of adoptive cellular immunotherapy in prostate cancer Author: Du, Xinhong; Yan, Zhenhong; Su, Peng; Liang, Hongyuan; Dong, Dan; Wang, Kefeng Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105395 PubMed DOI |
| 3. | Macrophages in colorectal cancer: Origin, function and significance of targeted therapy Author: Zhu, Yu; Xue, Yuan; Jiang, Jingzhi; Jin, Xuemei; Li, Li; Piao, Lihua Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105391 PubMed DOI |
| 4. | Dendritic cell-driven immune rebalancing as a systemic regulator of tumor and neurodegenerative microenvironments Author: Zhao, Peng-Yu; Wang, Kai-Kai; Zhang, Meng-Meng; Cao, Ze-Lin; Jin, Wei-Lin; Rozpedek-Kaminska, Wioletta Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105409 PubMed DOI |
| 5. | Overcoming immunotherapy resistance in extensive-stage small cell lung cancer: Insights into mechanisms and therapeutic opportunities Author: Guan, Ruonan; Zhang, Chenyue; Zhang, Juntao; Du, Shanshan; Wang, Haoyu; Zhang, Yulin; Abdi, Abdi Aziz Mohamed; Wang, Haiyong Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105411 PubMed DOI |
| 6. | Harnessing myeloid plasticity in CAR macrophages for solid tumor immunotherapy Author: You, Zhun; Lin, Zihan; Zhang, Yu; Xu, Libin; Zhang, Wen Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105414 PubMed DOI |
| 7. | Bile acids in the tumor immune microenvironment of hepatocellular carcinoma: Mechanisms of immunotherapy resistance and therapeutic opportunities Author: Yao, Songlin; Yang, Liu; Wang, Shurong; Shen, Jing; Li, Yaling; Guo, Shiwei; Cui, Xinya; Xiao, Zhangang; Wu, Zhigui Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105413 PubMed DOI |
| 8. | Research advances in dual-conversion therapy for hepatocellular carcinoma Author: Shao, Jingren; Han, Chuangye; Peng, Tao Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105404 PubMed DOI |
| 9. | Neoadjuvant immunotherapy in locally advanced head and neck squamous cell carcinoma: From oncologic outcomes to response-adaptive treatment de-escalation Author: You, Xiaokai; Jiang, Qiao; Xue, Wenrui; Zhang, Zhenyong; Gong, Ming; Zhuang, Yuan Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105410 PubMed DOI |
| 10. | Hybrid membrane nanosystems for cancer immunotherapy: Biomimetic design, immune activation, and translational potential Author: Cao, Ruihan; Wei, Qianqian; Yan, Si-si; Gong, Caifeng; Bu, Lin-lin; Wu, Qiuji Journal: CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2026; Vol. 225, Issue , pp. -. DOI: 10.1016/j.critrevonc.2026.105415 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共103条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
